We’ve recently updated our valuation analysis.

PaySign Valuation

Is PAYS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PAYS?

Other financial metrics that can be useful for relative valuation.

PAYS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.8x
Enterprise Value/EBITDA59.3x
PEG Ratio5.9x

Price to Sales Ratio vs Peers

How does PAYS's PS Ratio compare to its peers?

The above table shows the PS ratio for PAYS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.9x
SRT Startek
0.2x4.2%US$169.0m
LSAK Lesaka Technologies
0.8xn/aUS$246.9m
CTLP Cantaloupe
1.8x14.3%US$373.2m
IBEX IBEX
1x9.1%US$497.6m
PAYS PaySign
4.9x14.7%US$188.1m


Price to Earnings Ratio vs Industry

How does PAYS's PE Ratio compare vs other companies in the US IT Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.8%
n/an/an/a


Price to Sales Ratio vs Fair Ratio

What is PAYS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PAYS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.9x
Fair PS Ratio1.5x

Price-To-Sales vs Fair Ratio: PAYS is expensive based on its Price-To-Sales Ratio (4.9x) compared to the estimated Fair Price-To-Sales Ratio (1.5x).


Share Price vs Fair Value

What is the Fair Price of PAYS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PAYS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$3.40
US$3.81
+12.1%
8.5%US$4.25US$3.50n/a4
Feb ’24US$3.28
US$3.81
+16.2%
8.5%US$4.25US$3.50n/a4
Jan ’24US$2.58
US$3.81
+47.8%
8.5%US$4.25US$3.50n/a4
Dec ’23US$2.96
US$3.81
+28.8%
8.5%US$4.25US$3.50n/a4
Nov ’23US$2.45
US$3.75
+53.1%
6.7%US$4.00US$3.50n/a4
Oct ’23US$2.37
US$3.75
+58.2%
6.7%US$4.00US$3.50n/a4
Sep ’23US$2.95
US$3.75
+27.1%
6.7%US$4.00US$3.50n/a4
Aug ’23US$2.14
US$3.45
+61.2%
12.4%US$4.00US$2.80n/a4
Jul ’23US$1.53
US$3.45
+125.5%
12.4%US$4.00US$2.80n/a4
Jun ’23US$1.53
US$3.45
+125.5%
12.4%US$4.00US$2.80n/a4
May ’23US$1.87
US$3.44
+83.8%
20.8%US$4.00US$2.25n/a4
Apr ’23US$1.97
US$3.44
+74.5%
20.8%US$4.00US$2.25n/a4
Mar ’23US$2.10
US$4.00
+90.5%
17.7%US$5.00US$3.50n/a3
Feb ’23US$2.30
US$4.00
+73.9%
17.7%US$5.00US$3.50US$3.283
Jan ’23US$1.60
US$4.00
+150.0%
17.7%US$5.00US$3.50US$2.583
Dec ’22US$1.75
US$4.00
+128.6%
17.7%US$5.00US$3.50US$2.963
Nov ’22US$2.75
US$4.42
+60.6%
25.5%US$6.00US$3.50US$2.453
Oct ’22US$2.60
US$4.42
+69.9%
25.5%US$6.00US$3.50US$2.373
Sep ’22US$2.49
US$4.42
+77.4%
25.5%US$6.00US$3.50US$2.953
Aug ’22US$2.66
US$4.33
+62.9%
27.2%US$6.00US$3.50US$2.143
Jul ’22US$3.17
US$4.33
+36.7%
27.2%US$6.00US$3.50US$1.533
Jun ’22US$3.35
US$4.33
+29.4%
27.2%US$6.00US$3.50US$1.533
May ’22US$3.82
US$5.00
+30.9%
29.4%US$7.00US$3.50US$1.873
Apr ’22US$4.59
US$5.00
+8.9%
25.5%US$7.00US$3.50US$1.974
Mar ’22US$4.81
US$5.33
+10.7%
25.7%US$7.00US$3.30US$2.104
Feb ’22US$4.74
US$5.33
+12.3%
25.7%US$7.00US$3.30US$2.304


Discover undervalued companies